rs61753271

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_022725.4(FANCF):​c.385C>G​(p.Leu129Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000551 in 1,614,138 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L129I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00047 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00056 ( 0 hom. )

Consequence

FANCF
NM_022725.4 missense

Scores

4
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:8O:1

Conservation

PhyloP100: 1.16

Publications

7 publications found
Variant links:
Genes affected
FANCF (HGNC:3587): (FA complementation group F) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group F. [provided by RefSeq, Jul 2008]
GAS2 (HGNC:4167): (growth arrest specific 2) The protein encoded by this gene is a caspase-3 substrate that plays a role in regulating microfilament and cell shape changes during apoptosis. It can also modulate cell susceptibility to p53-dependent apoptosis by inhibiting calpain activity. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2017]
GAS2 Gene-Disease associations (from GenCC):
  • hearing loss disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hearing loss, autosomal recessive 125
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.030844986).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000473 (72/152366) while in subpopulation NFE AF = 0.000853 (58/68032). AF 95% confidence interval is 0.000677. There are 0 homozygotes in GnomAd4. There are 30 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022725.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FANCF
NM_022725.4
MANE Select
c.385C>Gp.Leu129Val
missense
Exon 1 of 1NP_073562.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FANCF
ENST00000327470.6
TSL:6 MANE Select
c.385C>Gp.Leu129Val
missense
Exon 1 of 1ENSP00000330875.3
GAS2
ENST00000528582.5
TSL:3
c.-408G>C
upstream_gene
N/AENSP00000432584.1
GAS2
ENST00000648096.1
n.-83G>C
upstream_gene
N/A

Frequencies

GnomAD3 genomes
AF:
0.000473
AC:
72
AN:
152248
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000852
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000564
AC:
141
AN:
249958
AF XY:
0.000523
show subpopulations
Gnomad AFR exome
AF:
0.0000638
Gnomad AMR exome
AF:
0.000174
Gnomad ASJ exome
AF:
0.0000996
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00106
Gnomad NFE exome
AF:
0.000929
Gnomad OTH exome
AF:
0.000819
GnomAD4 exome
AF:
0.000559
AC:
817
AN:
1461772
Hom.:
0
Cov.:
32
AF XY:
0.000543
AC XY:
395
AN XY:
727190
show subpopulations
African (AFR)
AF:
0.000119
AC:
4
AN:
33480
American (AMR)
AF:
0.000201
AC:
9
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000153
AC:
4
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
0.00124
AC:
66
AN:
53352
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000642
AC:
714
AN:
1111966
Other (OTH)
AF:
0.000331
AC:
20
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
58
117
175
234
292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000473
AC:
72
AN:
152366
Hom.:
0
Cov.:
33
AF XY:
0.000403
AC XY:
30
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41602
American (AMR)
AF:
0.00
AC:
0
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000853
AC:
58
AN:
68032
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000430
Hom.:
0
Bravo
AF:
0.000393
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000684
AC:
83
EpiCase
AF:
0.000545
EpiControl
AF:
0.000474

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
-
not provided (3)
-
2
-
Fanconi anemia (2)
-
2
-
Fanconi anemia complementation group F (2)
-
1
-
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.055
T
Eigen
Benign
0.00038
Eigen_PC
Benign
-0.13
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Benign
0.51
T
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.031
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Uncertain
2.2
M
PhyloP100
1.2
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-0.49
N
REVEL
Benign
0.069
Sift
Benign
0.99
T
Sift4G
Benign
0.15
T
Polyphen
0.99
D
Vest4
0.20
MVP
0.46
MPC
0.85
ClinPred
0.099
T
GERP RS
4.3
PromoterAI
0.033
Neutral
Varity_R
0.18
gMVP
0.11
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61753271; hg19: chr11-22646972; COSMIC: COSV104646809; API